TG Therapeutics Inc vs United Microelectronics Corp — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while United Microelectronics Corp trades at $21.12 (market cap $51.00B). The key difference: United Microelectronics Corp is far larger — about 6.2× TG Therapeutics Inc's market cap, and United Microelectronics Corp pays a 2.03% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | UMC | |
|---|---|---|
Market Cap | $8.26B | $51.00B |
Sector | Health | Technology |
52-Week High | $59.06 | $28.02 |
52-Week Low | $26.39 | $6.58 |
Enterprise Value | $8.50B | $48.57B |
Dividend Yield | — | 2.03% |
Trailing returns across standard periods
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →